U.S. Food and Drug Administration
Skip navigationFDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
horizontal rule
This week in FDA history.This weekly feature from 2006, the FDA's centennial year, highlights history and progress in the agency's first 100 years.A sampling of significant events in the Food and Drug Administration's first 100 years.
Photo with caption
Metered-dose inhalers are classed as combination products because they use a medical device to deliver a drug dose.
December 24, 2002:
The FDA Office of Combination Products is formed. Mandated under the Medical Device User Fee and Modernization Act, this office oversees review of products that fall into multiple jurisdictions within FDA.
 

FDA in 2006

Combination products (medical products that combine drugs, medical devices, and/or biological products) are increasingly incorporating cutting-edge, novel technologies that hold great promise for advancing patient care. Drug-eluting stents and inhaled insulin are two breakthrough new products approved since the Office of Combination Products was established. Other combination products anticipated include novel
drug-delivery systems, drug-device combinations that are tailored to the way an individual's genetic inheritance affects the body's response to drugs, nanotechnology, gene therapy systems and many other diagnostic and therapeutic treatments. The Office of Combination Products expects these products to continue to become more complicated as new technologies emerge and existing technologies mature.

More on combination products

This Week in FDA History Home

rule

FDA Centennial Home Page | FDA History

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff

link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page